Written answers

Tuesday, 17 May 2022

Department of Health

Medicinal Products

Photo of Neasa HouriganNeasa Hourigan (Dublin Central, Green Party)
Link to this: Individually | In context | Oireachtas source

650. To ask the Minister for Health his plans to make Kaftrio available to children with cystic fibrosis who have only one delta F508 mutation and as such have no other suitable modulator; and if he will make a statement on the matter. [24167/22]

Photo of Gary GannonGary Gannon (Dublin Central, Social Democrats)
Link to this: Individually | In context | Oireachtas source

683. To ask the Minister for Health if his attention has been drawn to the situation of 35 children with cystic fibrosis (details supplied) who are being denied access to the life-changing drug kaftrio; and if he will make a statement on the matter. [24368/22]

Photo of Stephen DonnellyStephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

I propose to take Questions Nos. 650 and 683 together.

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Comments

No comments

Log in or join to post a public comment.